Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncology (Anti-cancer Drugs)
1.2 Key Market Segments
1.2.1 Oncology (Anti-cancer Drugs) Segment by Type
1.2.2 Oncology (Anti-cancer Drugs) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncology (Anti-cancer Drugs) Market Overview
2.1 Global Market Overview
2.1.1 Global Oncology (Anti-cancer Drugs) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology (Anti-cancer Drugs) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncology (Anti-cancer Drugs) Market Competitive Landscape
3.1 Global Oncology (Anti-cancer Drugs) Sales by Manufacturers (2019-2024)
3.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology (Anti-cancer Drugs) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology (Anti-cancer Drugs) Sales Sites, Area Served, Product Type
3.6 Oncology (Anti-cancer Drugs) Market Competitive Situation and Trends
3.6.1 Oncology (Anti-cancer Drugs) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology (Anti-cancer Drugs) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncology (Anti-cancer Drugs) Industry Chain Analysis
4.1 Oncology (Anti-cancer Drugs) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncology (Anti-cancer Drugs) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncology (Anti-cancer Drugs) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2019-2024)
6.3 Global Oncology (Anti-cancer Drugs) Market Size Market Share by Type (2019-2024)
6.4 Global Oncology (Anti-cancer Drugs) Price by Type (2019-2024)
7 Oncology (Anti-cancer Drugs) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology (Anti-cancer Drugs) Market Sales by Application (2019-2024)
7.3 Global Oncology (Anti-cancer Drugs) Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology (Anti-cancer Drugs) Sales Growth Rate by Application (2019-2024)
8 Oncology (Anti-cancer Drugs) Market Segmentation by Region
8.1 Global Oncology (Anti-cancer Drugs) Sales by Region
8.1.1 Global Oncology (Anti-cancer Drugs) Sales by Region
8.1.2 Global Oncology (Anti-cancer Drugs) Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology (Anti-cancer Drugs) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology (Anti-cancer Drugs) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology (Anti-cancer Drugs) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology (Anti-cancer Drugs) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Oncology (Anti-cancer Drugs) Basic Information
9.1.2 Roche Oncology (Anti-cancer Drugs) Product Overview
9.1.3 Roche Oncology (Anti-cancer Drugs) Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Oncology (Anti-cancer Drugs) SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Novartis
9.2.1 Novartis Oncology (Anti-cancer Drugs) Basic Information
9.2.2 Novartis Oncology (Anti-cancer Drugs) Product Overview
9.2.3 Novartis Oncology (Anti-cancer Drugs) Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Oncology (Anti-cancer Drugs) SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Celgene
9.3.1 Celgene Oncology (Anti-cancer Drugs) Basic Information
9.3.2 Celgene Oncology (Anti-cancer Drugs) Product Overview
9.3.3 Celgene Oncology (Anti-cancer Drugs) Product Market Performance
9.3.4 Celgene Oncology (Anti-cancer Drugs) SWOT Analysis
9.3.5 Celgene Business Overview
9.3.6 Celgene Recent Developments
9.4 Amgen
9.4.1 Amgen Oncology (Anti-cancer Drugs) Basic Information
9.4.2 Amgen Oncology (Anti-cancer Drugs) Product Overview
9.4.3 Amgen Oncology (Anti-cancer Drugs) Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 Johnson and Johnson
9.5.1 Johnson and Johnson Oncology (Anti-cancer Drugs) Basic Information
9.5.2 Johnson and Johnson Oncology (Anti-cancer Drugs) Product Overview
9.5.3 Johnson and Johnson Oncology (Anti-cancer Drugs) Product Market Performance
9.5.4 Johnson and Johnson Business Overview
9.5.5 Johnson and Johnson Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Oncology (Anti-cancer Drugs) Basic Information
9.6.2 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Overview
9.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Eli lilly and Co
9.7.1 Eli lilly and Co Oncology (Anti-cancer Drugs) Basic Information
9.7.2 Eli lilly and Co Oncology (Anti-cancer Drugs) Product Overview
9.7.3 Eli lilly and Co Oncology (Anti-cancer Drugs) Product Market Performance
9.7.4 Eli lilly and Co Business Overview
9.7.5 Eli lilly and Co Recent Developments
9.8 Pfizer
9.8.1 Pfizer Oncology (Anti-cancer Drugs) Basic Information
9.8.2 Pfizer Oncology (Anti-cancer Drugs) Product Overview
9.8.3 Pfizer Oncology (Anti-cancer Drugs) Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Merck and Co.
9.9.1 Merck and Co. Oncology (Anti-cancer Drugs) Basic Information
9.9.2 Merck and Co. Oncology (Anti-cancer Drugs) Product Overview
9.9.3 Merck and Co. Oncology (Anti-cancer Drugs) Product Market Performance
9.9.4 Merck and Co. Business Overview
9.9.5 Merck and Co. Recent Developments
9.10 Sanofi
9.10.1 Sanofi Oncology (Anti-cancer Drugs) Basic Information
9.10.2 Sanofi Oncology (Anti-cancer Drugs) Product Overview
9.10.3 Sanofi Oncology (Anti-cancer Drugs) Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
10 Oncology (Anti-cancer Drugs) Market Forecast by Region
10.1 Global Oncology (Anti-cancer Drugs) Market Size Forecast
10.2 Global Oncology (Anti-cancer Drugs) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology (Anti-cancer Drugs) Market Size Forecast by Country
10.2.3 Asia Pacific Oncology (Anti-cancer Drugs) Market Size Forecast by Region
10.2.4 South America Oncology (Anti-cancer Drugs) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology (Anti-cancer Drugs) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oncology (Anti-cancer Drugs) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology (Anti-cancer Drugs) by Type (2025-2030)
11.1.2 Global Oncology (Anti-cancer Drugs) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology (Anti-cancer Drugs) by Type (2025-2030)
11.2 Global Oncology (Anti-cancer Drugs) Market Forecast by Application (2025-2030)
11.2.1 Global Oncology (Anti-cancer Drugs) Sales (Kilotons) Forecast by Application
11.2.2 Global Oncology (Anti-cancer Drugs) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
